Literature DB >> 1310762

Functions of the sequences at the ends of the inverted repeats of pseudorabies virus.

G F Rall1, S Kupershmidt, N Sugg, R A Veach, T Ben-Porat.   

Abstract

Two mutants were constructed to explore the functions of the sequences at the end of the S terminus of pseudorabies virus (PrV). In mutant vYa, 17 bp from the internal inverted repeat, as well as adjacent sequences from the L component, were deleted. In mutant v135/9, 143 bp from the internal inverted repeat (including sequences with homology to the pac-1 site of herpes simplex virus), as well as adjacent sequences from the L component, were deleted. Our aim in constructing these mutants was to ascertain whether equalization of the terminal regions of the S component would occur, whether genome termini that lack either the terminal 17 or 143 bp would be generated as a result of equalization of the repeats (thereby identifying the terminal nucleotides that may include cleavage signals), and whether inversion of the S component would occur (thereby ascertaining the importance of the deleted sequences in this process). The results obtained show the following (i) The removal of the terminal 17 or 143 bp of the internal S component, including the sequences with homology to the pac-1 site, does not affect the inversion of the Us. (ii) The equalization of both the vYa and the v135/9 inverted repeats occurs at high frequency, the terminal repeats being converted and becoming similar to the mutated internal inverted repeat. (iii) Mutants in which the 17 terminal base pairs (vYa) have been replaced by unrelated sequences are viable. However, the 143 terminal base pairs appear to be essential to virus survival; concatemeric v135/9 DNA with equalized, mutant-type, inverted repeats accumulates, but mature virions with such equalized repeats are not generated at high frequency. Since concatemeric DNA missing the 143 bp at both ends of the S component is not cleaved, the terminal 143 bp that include the sequences with homology to the pac-1 site are necessary for efficient cleavage. (iv) v135/9 intracellular DNA is composed mainly of arrays in which one S component (with two equalized inverted repeats both having the deletion) is bracketed by two L components in opposite orientations and in which two L components are in head-to-head alignment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310762      PMCID: PMC240876     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Inverted repetitions in the chromosome of herpes simplex virus.

Authors:  P Sheldrick; N Berthelot
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  Structural organization of the termini of the L and S components of the genome of pseudorabies virus.

Authors:  J M DeMarchi; Z Q Lu; G Rall; S Kupershmidt; T Ben-Porat
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

3.  Signals for site-specific cleavage of HSV DNA: maturation involves two separate cleavage events at sites distal to the recognition sequences.

Authors:  S L Varmuza; J R Smiley
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

4.  cis Functions involved in replication and cleavage-encapsidation of pseudorabies virus.

Authors:  C A Wu; L Harper; T Ben-Porat
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Sequence of the genome ends and of the junction between the ends in concatemeric DNA of pseudorabies virus.

Authors:  L Harper; J Demarchi; T Ben-Porat
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

6.  Construction of a double-jointed herpes simplex viral DNA molecule: inverted repeats are required for segment inversion, and direct repeats promote deletions.

Authors:  J R Smiley; B S Fong; W C Leung
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

7.  The cleavage recognition signal is contained within sequences surrounding an a-a junction in herpes simplex virus DNA.

Authors:  M Nasseri; E S Mocarski
Journal:  Virology       Date:  1988-11       Impact factor: 3.616

8.  Low-level inversion of the L component of pseudorabies virus is not dependent on sequence homology.

Authors:  G F Rall; S Kupershmidt; X Q Lu; T C Mettenleiter; T Ben-Porat
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

9.  Origin of replication of the DNA of a herpesvirus (pseudorabies).

Authors:  T Ben-Porat; R A Veach
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

10.  Specificity of cleavage in replicative-form DNA of bovine herpesvirus 1.

Authors:  W Hammerschmidt; H Ludwig; H J Buhk
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

View more
  5 in total

Review 1.  Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine.

Authors:  Lisa E Pomeranz; Ashley E Reynolds; Christoph J Hengartner
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

2.  Retroviral insertional activation in a herpesvirus: transcriptional activation of US genes by an integrated long terminal repeat in a Marek's disease virus clone.

Authors:  D Jones; P Brunovskis; R Witter; H J Kung
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

3.  Retroviral insertions into a herpesvirus are clustered at the junctions of the short repeat and short unique sequences.

Authors:  D Jones; R Isfort; R Witter; R Kost; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

4.  Analysis of the equalization of inverted repeats and neurovirulence using a pseudorabies virus mutant strain altered at the Ul/Ir junction.

Authors:  Z Boldogköi; A Braun; I Medveczky; R Glávits; B Gyúró; I Fodor
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

5.  Characterization of pseudorabies virus (PrV) cleavage-encapsidation proteins and functional complementation of PrV pUL32 by the homologous protein of herpes simplex virus type 1.

Authors:  Walter Fuchs; Barbara G Klupp; Harald Granzow; Tobias Leege; Thomas C Mettenleiter
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.